BFI Infinity’s Pfizer PFE Stock Holding History

BFI Infinity’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$452K	Buy	+15,866	New	+$422K	0.21%	48

Other funds holding PFE

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return

BFI Infinity's PFE Position: Q3 2026 in Review

BFI Infinity opened a new position in Pfizer (PFE) in Q3 2026: 15,866 shares worth $452K. The stake represents 0.21% of the portfolio and ranks #48 among its holdings.

479 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

BFI Infinity held 15,866 shares of Pfizer worth $452K as of Q3 2026.
Pfizer was a new BFI Infinity position in Q3 2026.
Pfizer made up 0.21% of BFI Infinity's portfolio in Q3 2026, its #48 holding.
479 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on BFI Infinity's 13F filing for Q3 2026, filed 16 Oct 2026.